Nystatin Tablets, USP (Oral) Rx only

Manufacturer
Chartwell RX, LLC
Effective date
2025-12-17
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
3
Source
full-release
Hydrated at
2026-05-31 21:50:43

Label at a glance#

ProductNystatin
Active ingredientNYSTATIN
Label structure10 sections

Indications and uses

Nystatin Tablets are intended for the treatment of non-esophageal mucus membrane gastrointestinal candidiasis.

Dosage and administration

The usual therapeutic dosage is one to two tablets (500,000 to 1,000,000 units nystatin) three times daily. Treatment should generally be continued for at least 48 hours after clinical cure to prevent relapse.

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

Nystatin, USP is an antimycotic polyene antibiotic obtained from Streptomyces noursei. Its structural formula:

Chemical StructureChemical Structure

C 47H 75NO 17                                                   M.W. 926.13

Nystatin tablets, USP are for oral administration and contain 500,000 units of nystatin, USP per tablet.
Nystatin tablets, USP contain the inactive ingredients: corn starch, confectioner sugar, dibasic calcium phosphate, FD&C yellow #6, FD&C red #40, FD&C blue #2, hydroxypropyl cellulose, hypromellose, microcrystalline cellulose, magnesium stearate, polyethylene glycol, polysorbate 80, talc and titanium dioxide.

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

Pharmacokinetics

SPL UNCLASSIFIED SECTION

Gastrointestinal absorption of nystatin is insignificant. Most orally administered nystatin is passed unchanged in the stool. In patients with renal insufficiency receiving oral therapy with conventional dosage forms, significant plasma concentrations of nystatin may occasionally occur.

Microbiology

SPL UNCLASSIFIED SECTION

Nystatin is both fungistatic and fungicidal in vitroagainst a wide variety of yeasts and yeast-like fungi. Candida albicansdemonstrates no significant resistance to nystatin in vitroon repeated subculture in increasing levels of nystatin; other Candidaspecies become quite resistant. Generally, resistance does not develop in vivo. Nystatin acts by binding to sterols in the cell membrane of susceptible Candidaspecies with a resultant change in membrane permeability allowing leakage of intracellular components. Nystatin exhibits no appreciable activity against bacteria, protozoa, or viruses.

INDICATIONS AND USAGE

INDICATIONS & USAGE SECTION

Nystatin Tablets are intended for the treatment of non-esophageal mucus membrane gastrointestinal candidiasis.

CONTRAINDICATIONS

CONTRAINDICATIONS SECTION

Nystatin tablets are contraindicated in patients with a history of hypersensitivity to any of their components.

PRECAUTIONS

PRECAUTIONS SECTION

General

SPL UNCLASSIFIED SECTION

This medication is not to be used for the treatment of systemic mycoses. Discontinue treatment if sensitization or irritation is reported during use.

Carcinogenesis, Mutagenesis, Impairment of Fertility

SPL UNCLASSIFIED SECTION

No long-term animal studies have been performed to evaluate carcinogenic potential. There also have been no studies to determine mutagenicity or whether this medication affects fertility in males or females.

Pregnancy

SPL UNCLASSIFIED SECTION

Teratogenic Effects

Category C

Animal reproduction studies have not been conducted with nystatin. It is also not known whether nystatin can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. Nystatin should be given to a pregnant woman only if clearly needed.

Nursing Mothers

SPL UNCLASSIFIED SECTION

It is not known whether nystatin is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when nystatin is administered to a nursing woman.

ADVERSE REACTIONS

ADVERSE REACTIONS SECTION

Nystatin is well tolerated even with prolonged therapy. Oral irritation and sensitization have been reported. (See PRECAUTIONS: General.)

Gastrointestinal

SPL UNCLASSIFIED SECTION

Diarrhea (including one case of bloody diarrhea), nausea, vomiting, gastrointestinal upset/disturbances.

Dermatologic

SPL UNCLASSIFIED SECTION

Rash, including urticaria has been reported rarely. Stevens-Johnson syndrome has been reported very rarely.

OVERDOSAGE

OVERDOSAGE SECTION

Oral doses of nystatin in excess of five million units daily have caused nausea and gastrointestinal upset. There have been no reports of serious toxic effects of superinfections (see CLINICAL PHARMACOLOGY, Pharmacokinetics).

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

The usual therapeutic dosage is one to two tablets (500,000 to 1,000,000 units nystatin) three times daily. Treatment should generally be continued for at least 48 hours after clinical cure to prevent relapse.

HOW SUPPLIED

HOW SUPPLIED SECTION

Nystatin Tablets, USP 500,000 Units are round brown, film-coated tablets debossed "HP51" on one side and plain on the other side are packaged in:
             Bottles of 90: NDC 62135-741-90

Store at 20° to 25°C (68° to 77°F). [See USP Controlled Room Temperature].


Manufactured by:
Vivimed Life Sciences Private Limited
Alathur, Kanchipuram – 603 110, Tamilnadu, India.
M.L. No.: TN00002327

Manufactured for:
Chartwell RX, LLC.
Congers, NY 10920

Revised: 08/2023

L71669

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Nystatin Tablets, USP (Oral), 500,000 units - NDC 62135-741-90 - 90's Bottle Label

bottle-labelbottle-label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
312059nystatin 500,000 UNT Oral TabletPSN3
312059nystatin 500000 UNT Oral TabletSCD3
312059nystatin 500,000 UNT Oral TabletSY3

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
NYSTATIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130362135741907GTIN-13: 0362135741907
EAN-13: 0362135741907
GTIN-12: 362135741907
UPC-A: 362135741907
GTIN storage (14 digits): 00362135741907
nystatin-bottle-label.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
e29fe634-dc25-094c-c77f-5d09c3eceb3eProduct name520260107
e57b6340-9387-3f9a-7307-511c81791375Product name320221214
544f8e8d-6389-eeeb-9586-aa447c08dcc7Product name520210614
1629e00f-54fb-4a43-8306-b58442b23902Product name920200430
854ec07b-1cd7-a5db-235a-7aa24d3cf97aProduct name320180628
19b9f4c1-15e9-edcc-4c16-f01ecfb5c549Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
62135-741-90Nystatin90 in 1 BOTTLETABLET, FILM COATED903

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
62135-741-90EA - Each62135-74149248e91-f7df-438f-964b-df4d7c8e933a12023-09-05

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
62135-74162135-741-90

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 17 matching rows.

Source Document#

Source XML

Orange Book application contexts#

All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.

Orange Book application contexts page 1 of 1 · 1 matching rows.

Source provenance: Browse the complete Orange Book source catalog · source snapshot 45.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A062474-001NYSTATINNYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A062474-001AA

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-11-14 07:37:172026-10A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22d4dbc9d85df4…
2026-10-15 13:18:302026-09A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22c2088c7a36db…
2026-09-14 22:38:342026-08A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2284e616aacf4f…
2026-08-18 06:07:402026-07A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-226a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2203ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-222680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-225bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2279d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-221e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-228072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-225c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-225d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-224b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2274a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-2287673890dc5c…
2021-03-12 10:30 UTC2021-03A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-225aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-228869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-223f01610625f2…
2019-09-15 20:21 UTC2019-09A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22b00525d2431f…
2019-07-19 19:46 UTC2019-07A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-226a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-221c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-229b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-223f0d92c62455…
2023-05-13 08:27 UTC2023-05A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-22053a50430f4f…
2023-01-26 05:58 UTC2023-01A062474-001NYSTATIN500,000 UNITSTABLET / ORALAA1983-12-223bdfa0b2c4d7…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 45 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-11-14 07:37:172026-10A062474-001AA1d4dbc9d85df4…
2026-10-15 13:18:302026-09A062474-001AA1c2088c7a36db…
2026-09-14 22:38:342026-08A062474-001AA184e616aacf4f…
2026-08-18 06:07:402026-07A062474-001AA1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A062474-001AA1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A062474-001AA131067a03dcf5…
2025-08-23 18:47 UTC2025-08A062474-001AA16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A062474-001AA1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A062474-001AA1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A062474-001AA103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A062474-001AA12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A062474-001AA15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A062474-001AA1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A062474-001AA1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A062474-001AA179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A062474-001AA1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A062474-001AA11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A062474-001AA18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A062474-001AA15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A062474-001AA15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A062474-001AA14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A062474-001AA174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A062474-001AA1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A062474-001AA1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A062474-001AA187673890dc5c…
2021-03-12 10:30 UTC2021-03A062474-001AA15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A062474-001AA18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A062474-001AA1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A062474-001AA13f01610625f2…
2019-09-15 20:21 UTC2019-09A062474-001AA1b00525d2431f…
2019-07-19 19:46 UTC2019-07A062474-001AA1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A062474-001AA16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A062474-001AA11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A062474-001AA1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A062474-001AA1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A062474-001AA19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A062474-001AA1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A062474-001AA13f0d92c62455…
2023-05-13 08:27 UTC2023-05A062474-001AA1053a50430f4f…
2023-01-26 05:58 UTC2023-01A062474-001AA13bdfa0b2c4d7…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NystatinNYSTATINChartwell RX, LLC30175930-f5fa-403d-a3ac-3bdbbe7236412025-12-17Adverse reactionsExact identifier
ndc (package): 62135-741-90
ndc (product): 62135-741
ndc11 (package): 62135074190
spl id: 462a7357-7985-7f48-e063-6294a90ac5c8
spl set id: 30175930-f5fa-403d-a3ac-3bdbbe723641

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.